CYBB and central nervous system cancer: Therefore, we need to overcome these limitations and further study the correlation of NOX2 with clinical outcomes and other potential confounding factors, extending to a diverse glioma cohort with more appropriate sample sizes to overcome these limitations and identify clearer impacts.